8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001415889-16-006879
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading vtgn8k_aug162016.htm…